SEC Form 4 · accession 0001209191-18-047488
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T Lafrance
Director
Period of report
Aug 15, 2018
Accepted (ET)
Aug 17, 2018 · 5:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 15, 2018 | A | 2,500 | $0.00 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.31 | Aug 15, 2018 | A | 10,000 | A | — | Aug 14, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The shares will vest on the earlier of August 15, 2019 or the date of the next annual meeting of stockholders.